Clinical Trial Update: In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating in-human CXCR4 imaging with [68Ga]-Pentixafor-PET in hematologic and solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erdheim-chester Disease
• Histiocytic Neoplasms
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Rosai-dorfman Disease

Drugs mentioned

• [68Ga]-Pentixafor-PET (CXCR4-targeted radiotracer for PET imaging)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-Hodgkin Lymphoma, Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING